Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Love Ted W
Relationship:   Director
City:   Sunnyvale
State:   CA
   
Insider Summary:
  
   
Companies Owned :   10    
Direct Shares   249,789    

Indirect Shares

   0      
Direct Value   $2,458,946    

Indirect Value

   $0      
Total Shares   249,789      
Total Value   $2,458,946      


Nuvelo Inc $1,193 Onyx Pharmaceuticals Inc $0 Amicus Therapeutics Inc $1,389,910 Royalty Pharma Plc $1,034,348 Gilead Sciences Inc $33,495 Nuvelo Inc $1,193 Onyx Pharmaceuticals Inc $0 Amicus Therapeutics Inc $1,389,910 Royalty Pharma Plc $1,034,348 Gilead Sciences Inc $33,495
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Nuvelo Inc ABIO Director 2008-05-30 3,580 2004-02-27 0    Premium*  
            Onyx Pharmaceuticals Inc ONXX EVP, R&D and Tech. Ope... 2012-07-25 77,756 2010-02-01 0    Premium*  
            Santarus Inc SNTS Director 2014-01-02 0 2012-03-09 0    Premium*  
            Amicus Therapeutics Inc FOLD Director 2020-06-04 131,000 2014-03-12 0    Premium*  
            Global Blood Therapeutics, Inc. GBT President and CEO, Dir... 2022-10-05 0 2022-10-05 0    Premium*  
            Cascadian Therapeutics, Inc CASC Director 2018-03-09 0 2015-09-05 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2020-07-02 0 2019-09-18 0    Premium*  
            Royalty Pharma Plc RPRX Director 2023-06-23 36,941 0    Premium*  
            Seagen Inc SGEN 2023-12-14 0 2020-08-17 0    Premium*  
            Gilead Sciences Inc GILD Director 2024-02-02 512 2024-02-02 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
GILD Gilead Sciences Inc Director   •       •      –    2024-02-02 4 A $0.00 $0 D/D 512 512 0 -
SGEN Seagen Inc   –       •      –    2023-12-14 4 D $229.00 $974,395 D/D (4,255) 0 0 -
RPRX Royalty Pharma Plc Director   –       •      –    2023-06-23 4 A $0.00 $0 D/D 7,747 36,941 0 -
SGEN Seagen Inc Director   –       •      –    2023-05-31 4 A $0.00 $0 D/D 2,044 6,748 0 -
GBT Global Blood Therapeutics... President and CEO   •       •      –    2022-10-05 4 D $0.00 $0 I/I (346,300) 0 0 -
GBT Global Blood Therapeutics... President and CEO   •       •      –    2022-10-05 4 D $0.00 $0 D/D (576,318) 0 0 -
GBT Global Blood Therapeutics... President and CEO   •       •      –    2022-09-27 4 OE $16.40 $299,972 D/D 18,291 576,318 0 -
GBT Global Blood Therapeutics... President and CEO   •       •      –    2022-09-13 4 GA $0.00 $0 I/I 35,300 119,650 0 -
GBT Global Blood Therapeutics... President and CEO   •       •      –    2022-09-13 4 GD $0.00 $0 D/D 35,300 558,027 0 -
GBT Global Blood Therapeutics... President and CEO   •       •      –    2022-09-09 4 GD $0.00 $0 D/D 221,200 593,327 0 -
GBT Global Blood Therapeutics... President and CEO   •       •      –    2022-09-01 4 D $68.15 $626,980 D/D (9,200) 814,527 0 -
GBT Global Blood Therapeutics... President and CEO   •       •      –    2022-09-01 4 OE $0.00 $0 D/D 18,553 823,727 0 -
GBT Global Blood Therapeutics... President and CEO   •       •      –    2022-08-01 4 D $32.40 $324,583 D/D (10,018) 805,174 0 -
GBT Global Blood Therapeutics... President and CEO   •       •      –    2022-08-01 4 OE $0.00 $0 D/D 20,205 815,192 0 -
RPRX Royalty Pharma Plc Director   –       •      –    2022-06-24 4 A $0.00 $0 D/D 6,328 29,194 0 -
SGEN Seagen Inc Director   –       •      –    2022-05-13 4 A $0.00 $0 D/D 1,503 4,704 0 -
GBT Global Blood Therapeutics... President and CEO   •       •      –    2022-03-01 4 D $29.87 $121,690 D/D (4,074) 794,987 0 -
GBT Global Blood Therapeutics... President and CEO   •       •      –    2022-03-01 4 OE $0.00 $0 D/D 9,445 799,061 0 -
GBT Global Blood Therapeutics... President and CEO   •       •      –    2022-02-28 4 A $25.37 $21,285 D/D 839 789,616 0 -
GBT Global Blood Therapeutics... President and CEO   •       •      –    2022-02-01 4 D $29.33 $308,874 D/D (10,531) 788,777 0 -
GBT Global Blood Therapeutics... President and CEO   •       •      –    2022-02-01 4 OE $0.00 $0 D/D 29,955 799,308 0 -
GBT Global Blood Therapeutics... President and CEO   •       •      –    2021-09-01 4 D $29.85 $139,788 D/D (4,683) 794,174 0 -
GBT Global Blood Therapeutics... President and CEO   •       •      –    2021-09-01 4 OE $0.00 $0 D/D 9,444 798,857 0 -
GBT Global Blood Therapeutics... President and CEO   •       •      –    2021-08-01 4 OE $0.00 $0 D/D 29,955 804,266 0 -
GBT Global Blood Therapeutics... President and CEO   •       •      –    2021-08-01 4 D $27.33 $405,932 D/D (14,853) 789,413 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us